Oxotremorine treatment reduces repetitive behaviors in BTBR t+ tf/j mice

Dionisio A. Amodeo, Julia Yi, John A. Sweeney, Michael E. Ragozzino

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Repetitive behaviors with restricted interests is one of the core criteria for the diagnosis of autism spectrum disorder (ASD). Current pharmacotherapies that target the dopaminergic or serotonergic systems have limited effectiveness in treating repetitive behaviors. Previous research has demonstrated that administration of muscarinic cholinergic receptor (mAChR) antagonists can exacerbate motor stereotypies while mAChR agonists reduce stereotypies. The present study determined whether the mAChR agonist, oxotremorine affected repetitive behaviors in the BTBR T+ tf/J (BTBR) mouse model of autism. To test the effects of oxotremorine on repetitive behaviors, marble burying and grooming behavior were measured in BTBR mice and compared to that in C57BL/6J (B6) mice. The effects of oxotremorine on locomotor activity was also measured. Thirty minutes before each test, mice received an intraperitoneal injection of saline, 0.001mg or 0.01mg of oxotremorine methiodide. Saline treated BTBR mice exhibited increased marble burying and self-grooming behavior compared to that of saline-treated B6 mice. Oxotremorine significantly reduced marble burying and self48 grooming behavior in BTBR mice, but had no significant effect in B6 mice. In addition, oxotremorine did not affect locomotor activity in BTBR mice, but significantly reduced locomotor activity in B6 mice at the 0.01mg dose. These findings demonstrate that activation of mAChRs reduces repetitive behavior in the BTBR mouse and suggest that treatment with a mAChR agonist may be effective in reducing repetitive behaviors in ASD.

Original languageEnglish (US)
Article number17
JournalFrontiers in Synaptic Neuroscience
Volume6
Issue numberJUL
DOIs
StatePublished - 2014

Fingerprint

Oxotremorine
Muscarinic Receptors
Muscarinic Agonists
Grooming
Calcium Carbonate
Cholinergic Receptors
Locomotion
Therapeutics
Cholinergic Antagonists
Autistic Disorder
Intraperitoneal Injections

Keywords

  • Acetylcholine
  • Autism
  • Grooming
  • Marble burying
  • Muscarinic receptors
  • Repetitive behaviors

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Cell Biology

Cite this

Oxotremorine treatment reduces repetitive behaviors in BTBR t+ tf/j mice. / Amodeo, Dionisio A.; Yi, Julia; Sweeney, John A.; Ragozzino, Michael E.

In: Frontiers in Synaptic Neuroscience, Vol. 6, No. JUL, 17, 2014.

Research output: Contribution to journalArticle

Amodeo, Dionisio A. ; Yi, Julia ; Sweeney, John A. ; Ragozzino, Michael E. / Oxotremorine treatment reduces repetitive behaviors in BTBR t+ tf/j mice. In: Frontiers in Synaptic Neuroscience. 2014 ; Vol. 6, No. JUL.
@article{41409b0fe729409ab1c6ac2e8a4cde07,
title = "Oxotremorine treatment reduces repetitive behaviors in BTBR t+ tf/j mice",
abstract = "Repetitive behaviors with restricted interests is one of the core criteria for the diagnosis of autism spectrum disorder (ASD). Current pharmacotherapies that target the dopaminergic or serotonergic systems have limited effectiveness in treating repetitive behaviors. Previous research has demonstrated that administration of muscarinic cholinergic receptor (mAChR) antagonists can exacerbate motor stereotypies while mAChR agonists reduce stereotypies. The present study determined whether the mAChR agonist, oxotremorine affected repetitive behaviors in the BTBR T+ tf/J (BTBR) mouse model of autism. To test the effects of oxotremorine on repetitive behaviors, marble burying and grooming behavior were measured in BTBR mice and compared to that in C57BL/6J (B6) mice. The effects of oxotremorine on locomotor activity was also measured. Thirty minutes before each test, mice received an intraperitoneal injection of saline, 0.001mg or 0.01mg of oxotremorine methiodide. Saline treated BTBR mice exhibited increased marble burying and self-grooming behavior compared to that of saline-treated B6 mice. Oxotremorine significantly reduced marble burying and self48 grooming behavior in BTBR mice, but had no significant effect in B6 mice. In addition, oxotremorine did not affect locomotor activity in BTBR mice, but significantly reduced locomotor activity in B6 mice at the 0.01mg dose. These findings demonstrate that activation of mAChRs reduces repetitive behavior in the BTBR mouse and suggest that treatment with a mAChR agonist may be effective in reducing repetitive behaviors in ASD.",
keywords = "Acetylcholine, Autism, Grooming, Marble burying, Muscarinic receptors, Repetitive behaviors",
author = "Amodeo, {Dionisio A.} and Julia Yi and Sweeney, {John A.} and Ragozzino, {Michael E.}",
year = "2014",
doi = "10.3389/fnsyn.2014.00017",
language = "English (US)",
volume = "6",
journal = "Frontiers in Synaptic Neuroscience",
issn = "1663-3563",
publisher = "Frontiers Research Foundation",
number = "JUL",

}

TY - JOUR

T1 - Oxotremorine treatment reduces repetitive behaviors in BTBR t+ tf/j mice

AU - Amodeo, Dionisio A.

AU - Yi, Julia

AU - Sweeney, John A.

AU - Ragozzino, Michael E.

PY - 2014

Y1 - 2014

N2 - Repetitive behaviors with restricted interests is one of the core criteria for the diagnosis of autism spectrum disorder (ASD). Current pharmacotherapies that target the dopaminergic or serotonergic systems have limited effectiveness in treating repetitive behaviors. Previous research has demonstrated that administration of muscarinic cholinergic receptor (mAChR) antagonists can exacerbate motor stereotypies while mAChR agonists reduce stereotypies. The present study determined whether the mAChR agonist, oxotremorine affected repetitive behaviors in the BTBR T+ tf/J (BTBR) mouse model of autism. To test the effects of oxotremorine on repetitive behaviors, marble burying and grooming behavior were measured in BTBR mice and compared to that in C57BL/6J (B6) mice. The effects of oxotremorine on locomotor activity was also measured. Thirty minutes before each test, mice received an intraperitoneal injection of saline, 0.001mg or 0.01mg of oxotremorine methiodide. Saline treated BTBR mice exhibited increased marble burying and self-grooming behavior compared to that of saline-treated B6 mice. Oxotremorine significantly reduced marble burying and self48 grooming behavior in BTBR mice, but had no significant effect in B6 mice. In addition, oxotremorine did not affect locomotor activity in BTBR mice, but significantly reduced locomotor activity in B6 mice at the 0.01mg dose. These findings demonstrate that activation of mAChRs reduces repetitive behavior in the BTBR mouse and suggest that treatment with a mAChR agonist may be effective in reducing repetitive behaviors in ASD.

AB - Repetitive behaviors with restricted interests is one of the core criteria for the diagnosis of autism spectrum disorder (ASD). Current pharmacotherapies that target the dopaminergic or serotonergic systems have limited effectiveness in treating repetitive behaviors. Previous research has demonstrated that administration of muscarinic cholinergic receptor (mAChR) antagonists can exacerbate motor stereotypies while mAChR agonists reduce stereotypies. The present study determined whether the mAChR agonist, oxotremorine affected repetitive behaviors in the BTBR T+ tf/J (BTBR) mouse model of autism. To test the effects of oxotremorine on repetitive behaviors, marble burying and grooming behavior were measured in BTBR mice and compared to that in C57BL/6J (B6) mice. The effects of oxotremorine on locomotor activity was also measured. Thirty minutes before each test, mice received an intraperitoneal injection of saline, 0.001mg or 0.01mg of oxotremorine methiodide. Saline treated BTBR mice exhibited increased marble burying and self-grooming behavior compared to that of saline-treated B6 mice. Oxotremorine significantly reduced marble burying and self48 grooming behavior in BTBR mice, but had no significant effect in B6 mice. In addition, oxotremorine did not affect locomotor activity in BTBR mice, but significantly reduced locomotor activity in B6 mice at the 0.01mg dose. These findings demonstrate that activation of mAChRs reduces repetitive behavior in the BTBR mouse and suggest that treatment with a mAChR agonist may be effective in reducing repetitive behaviors in ASD.

KW - Acetylcholine

KW - Autism

KW - Grooming

KW - Marble burying

KW - Muscarinic receptors

KW - Repetitive behaviors

UR - http://www.scopus.com/inward/record.url?scp=84904739369&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904739369&partnerID=8YFLogxK

U2 - 10.3389/fnsyn.2014.00017

DO - 10.3389/fnsyn.2014.00017

M3 - Article

C2 - 25165445

AN - SCOPUS:84904739369

VL - 6

JO - Frontiers in Synaptic Neuroscience

JF - Frontiers in Synaptic Neuroscience

SN - 1663-3563

IS - JUL

M1 - 17

ER -